Pfizer Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-29 | 2025-12-31 | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-12-31 | 2024-09-29 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14.45B | 17.56B | 16.65B | 14.65B | 13.71B | 17.76B | 17.70B | 13.28B |
| Cost of Goods Sold | 4.73B | 5.27B | 4.17B | 5.23B | 3.89B | 4.79B | 6.93B | 5.04B |
| Gross Profit | 9.72B | 12.29B | 12.48B | 9.42B | 9.83B | 12.97B | 10.77B | 8.24B |
| R&D Expenses | 2.63B | 3.42B | 3.94B | 2.44B | 2.18B | 3.02B | 2.56B | 2.68B |
| Operating Expenses | 5.69B | 8.60B | 8.93B | 5.84B | 5.20B | 7.24B | 5.80B | 6.36B |
| Operating Income | 4.03B | 3.69B | 3.55B | 3.58B | 4.62B | 5.72B | 4.97B | 1.88B |
| Other Income / Gains | -862.0M | -5.33B | -216.0M | -531.0M | -1.84B | -5.74B | -253.0M | -1.98B |
| Net Income | 2.69B | -1.65B | 3.54B | 2.91B | 2.97B | 403.0M | 4.47B | 24.0M |
| EPS (Diluted) | 0.47 | -0.29 | 0.62 | 0.51 | 0.523 | 0.072 | 0.789 | 0.004 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.673 | 0.70 | 0.749 | 0.643 | 0.717 | 0.73 | 0.608 | 0.621 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 2.96B | 3.73B | 3.19B | 3.40B | 3.02B | 4.23B | 3.24B | 3.69B |
| Other Expenses | 100.0M | 1.45B | 1.81B | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 10.42B | 13.87B | 13.10B | 11.08B | 9.09B | 12.04B | 12.73B | 11.40B |
| Interest Income | 115.0M | 166.0M | 138.0M | 156.0M | 143.0M | 170.0M | 116.0M | 130.0M |
| Interest Expense | 668.0M | 711.0M | 652.0M | 654.0M | 654.0M | 739.0M | 783.0M | 778.0M |
| Depreciation And Amortization | 1.18B | 1.69B | 1.66B | 1.63B | 1.62B | 1.79B | 1.75B | 1.73B |
| Ebitda | 5.21B | 756.0M | 5.65B | 5.32B | 5.06B | 5.14B | 7.25B | 2.40B |
| Ebitdaratio | 0.361 | 0.043 | 0.339 | 0.363 | 0.369 | 0.29 | 0.41 | 0.181 |
| Operating Income Ratio | 0.279 | 0.21 | 0.213 | 0.244 | 0.337 | 0.322 | 0.281 | 0.141 |
| Income Before Tax | 3.17B | -1.64B | 3.33B | 3.04B | 2.78B | -10.0M | 4.71B | -103.0M |
| Income Before Tax Ratio | 0.219 | -0.094 | 0.20 | 0.208 | 0.203 | -0.001 | 0.266 | -0.008 |
| Income Tax Expense | 461.0M | -2.0M | -216.0M | 141.0M | -189.0M | -421.0M | 234.0M | -134.0M |
| Net Income Ratio | 0.186 | -0.094 | 0.213 | 0.199 | 0.216 | 0.023 | 0.253 | 0.002 |
| Epsdiluted | 0.47 | -0.29 | 0.62 | 0.51 | 0.52 | 0.072 | 0.784 | 0.004 |
| Weighted Average Shs Out | 5.69B | 5.68B | 5.68B | 5.68B | 5.67B | 5.67B | 5.67B | 5.67B |
| Weighted Average Shs Out Dil | 5.73B | 5.69B | 5.71B | 5.71B | 5.71B | 5.70B | 5.71B | 5.70B |